Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism M1 receptor agonists(Muscarinic acetylcholine receptor M1 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H18N2O2 |
InChIKeyFXBXWJPMXQHOGD-UVTIVQHFSA-N |
CAS Registry149929-39-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | Phase 2 | US | 13 Nov 2001 | |
Alzheimer Disease | Phase 2 | US | 28 Jun 2000 | |
Cognition Disorders | Phase 2 | - | - | - |